E. Ohman J:or Asset Management AB
Position in DNLI — Denali Therapeutics Inc.
CIK 2009396
STOCKHOLM, V7
Position in DNLI
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$4,115,200
New position
Shares Held
160,000
first reported quarter
Ownership
0.100%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#73
of 286 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026E. Ohman J:or Asset Management AB holds $53,160,442 across 15 Biotechnology names. DNLI ranks #3 (7.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CYTK |
Cytokinetics Inc
|
304,611 | $25,949,811 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,823 | $4,382,648 | |
| 3 | DNLI |
Denali Therapeutics Inc.
This page
|
160,000 | $4,115,200 | |
| 4 | OCUL |
Ocular Therapeutix, Inc
|
385,000 | $3,780,700 | |
| 5 | VERA |
Vera Therapeutics, Inc.
|
85,777 | $3,680,691 | |
| 6 | TARS |
Tarsus Pharmaceuticals, Inc.
|
45,794 | $2,882,274 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,840 | $2,394,393 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,584 | $1,379,921 |
All Filings in DNLI
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,115,200 | 160,000 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||